Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Biopharma (CBIO) Other Working Capital Changes (2016 - 2026)

Crescent Biopharma (CBIO) has disclosed Other Working Capital Changes for 12 consecutive years, with -$101000.0 as the latest value for Q1 2026.

  • For Q1 2026, Other Working Capital Changes changed N/A year-over-year to -$101000.0; the TTM value through Mar 2026 reached -$309000.0, down 293.85%, while the annual FY2025 figure was -$162000.0, 78.15% up from the prior year.
  • Other Working Capital Changes hit -$101000.0 in Q1 2026 for Crescent Biopharma, up from -$222000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $240103.0 in Q1 2023 and bottomed at -$762531.0 in Q2 2023.
  • Average Other Working Capital Changes over 5 years is -$180717.7, with a median of -$230847.0 recorded in 2022.
  • Year-over-year, Other Working Capital Changes tumbled 538.98% in 2022 and then skyrocketed 200.17% in 2023.
  • Crescent Biopharma's Other Working Capital Changes stood at -$261549.0 in 2022, then surged by 74.58% to -$66486.0 in 2023, then surged by 81.99% to -$11971.0 in 2024, then plummeted by 1754.48% to -$222000.0 in 2025, then soared by 54.5% to -$101000.0 in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$101000.0, -$222000.0, and $14000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.